Cancer data platform operator MedBanks raised the capital in a series D-plus round led by Tencent, also a contributor to its series D in January.
Internet group Tencent has led a RMB1bn ($142m) series D-plus round for China-based oncology data platform developer Medbanks Network Technology, DealStreetAsia reported today, citing a company statement.
The round included telecommunications equipment maker China Electronics Corporation, Eight Roads Ventures and F-Prime Capital, which both invest on behalf of financial services and investment group Fidelity, as well as Wu Capital, IDG Capital and CICC Capital.
Founded in 2014, Medbanks operates a cancer data platform equipped with a natural language processing-equipped smart…
